Broadfin Capital’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-672,922
| Closed | -$26.9M | – | 74 |
|
|
2015
Q4 | $26.9M | Sell |
672,922
-948,910
| -59% | -$38M | 1.66% | 13 |
|
|
2015
Q3 | $46.2M | Sell |
1,621,832
-138,687
| -8% | -$3.95M | 2.57% | 6 |
|
|
2015
Q2 | $58M | Sell |
1,760,519
-50,000
| -3% | -$1.65M | 3.12% | 6 |
|
|
2015
Q1 | $52.1M | Sell |
1,810,519
-256,200
| -12% | -$7.37M | 4.06% | 6 |
|
|
2014
Q4 | $56.3M | Sell |
2,066,719
-13,800
| -0.7% | -$376K | 4.89% | 4 |
|
|
2014
Q3 | $44.3M | Hold |
2,080,519
| – | – | 4.65% | 5 |
|
|
2014
Q2 | $46.7M | Buy |
2,080,519
+275,167
| +15% | +$6.18M | 4.56% | 4 |
|
|
2014
Q1 | $45.6M | Buy |
1,805,352
+731,304
| +68% | +$18.5M | 4.42% | 4 |
|
|
2013
Q4 | $24.7M | Sell |
1,074,048
-200
| -0% | -$4.6K | 3.26% | 10 |
|
|
2013
Q3 | $20.5M | Hold |
1,074,248
| – | – | 3.63% | 8 |
|
|
2013
Q2 | $15.5M | Buy |
+1,074,248
| New | +$15.5M | 3.03% | 13 |
|